Skip to main contentAll experts

ProfessorPraveen Anand

Professor

Department of Brain Sciences - Faculty of Medicine

  • Professor
    Department of Brain Sciences - Faculty of Medicine
  • 020 3313 3319 (Work)
  • Area A Grd Floor, Unknown, Hammersmith Campus, United Kingdom

PROFESSIONAL ACTIVITIES

  • EXTERNAL COMMITTEE
    Scientific Advisory Board
    1 Jan 2013
  • GUEST LECTURE
    Speaker
    1 Jan 2013
    European Pain Congress (EFIC)
  • GUEST LECTURE
    Speaker at Drug validation
    1 Jan 2013
    British Embassy Tokyo / Royal Society of Chemistry
  • GUEST LECTURE
    Speaker
    1 Jan 2012
    International Society of Hypertension
  • GUEST LECTURE
    Invited speaker
    1 Jan 2011
    World Congress of Neurology
  • COLLABORATION
    Mayo Clinic, Barcelona, Haifa, Osaka and Rio de Janeiro
    1 Jan 2011 - 31 Dec 2013
    CHEPS (contact heat evoked potentials) developed as a practical clinical diagnostic test (substitute for the invasive skin biopsies for diagnosing small fibre neuropathy), led international normative data group. Data presentation at American Neurological Association, ANA, 2013
  • EXTERNAL COMMITTEE
    Scientific Advisory Board
    1 Jan 2011
  • EXTERNAL COMMITTEE
    Wellcome Trust Seeding Drug Discovery Committee
    1 Jan 2011 - 31 Dec 2012
  • GUEST LECTURE
    Invited Speaker
    1 Jan 2010
    International Congress of Clinical Neurophysiology
  • GUEST LECTURE
    Invited Speaker
    1 Jan 2010
    Association of British Neurologists Annual meeting, .
  • GUEST LECTURE
    Speaker at the Combined Orthopaedic Associations meeting
    1 Jan 2010
    Combined Orthopaedic Associations (USA, Canada, UK),
  • GUEST LECTURE
    Speaker at the meeting on Neurotoxins
    1 Jan 2010
    The Royal Society,
  • EXTERNAL COMMITTEE
    Advisory Council
    1 Jan 2008
  • EDITORIAL BOARD
    Pain
    1 Aug 2005
    Editorial Board
  • COLLABORATION
    Astellas,
    clinical study with Qutenza, high dose capsaicin patch, new indication to prevent pain from subcutaneous infusion of prostacyclin in patients with pulmonary hypertension. 2013
  • COLLABORATION
    Creabilis Pharma,
    successful clinical trial for itch with CT327. 2013. First in class.
  • COLLABORATION
    European Federation of Neurological Societies Task Force
    UK representative of the European Federation of Neurological Societies Task Force on Pain Management, responsibility to address required standards of quantitative sensory testing and skin / nerve biopsies in the assessment of patients with neuropathic pain
  • COLLABORATION
    GlaxoSmithKline
    Successful Phase II clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury. 2011. Drug first in class.
  • COLLABORATION
    Spinifex Pharma,
    EMA401 clinical trial positive results for EMA401 in postherpetic neuralgia: results presented at the World Congress of Pain in Milan in 2012. First in class
  • COLLABORATION
    New UK Govt. Department of Business, Innovation and Skills, UK drug development initiative, with Royal Society of Chemistry, linking key academics with pharma in UK and Japan - UK delegate and speaker at the British Embassy in Tokyo workshop on novel Drug Target Validation in January 2013